These findings indicate that FGF‐23 might have diagnostic potential for early detection of CKD and early phosphate derangement in cats and that phosphate dysregulation may be ongoing in the early stage of CKD before azotemia and hyperphosphatemia occur. Here, FGF23 is linked to chronic kidney disease.